Revilico
1 known investors
Revilico builds an operating system for pharmaceutical R&D that unifies computational drug discovery tools—including molecular dynamics, quantum chemistry, generative chemistry, and virtual cell simulations—with integrated wet-lab validation. The platform serves pharmaceutical researchers and biotech companies developing small molecule drugs, covering all phases from target identification through lead optimization and preclinical development.
Founders & leadership
Investors · 1
Competitors · 3
by search overlap
Revalia Bio, Inc.4 shared keywordsRevalia Bio uses AI to convert donated human organs and tissues into multi-modal biological datasets and decision-ready insights for drug and device development. It operates an Organ ICU facility and works with organ procurement organizations and healthcare institutions to serve pharma, biotech, and medical device companies.
Pelico4 shared keywordsPelico provides an AI-native operations platform for complex manufacturers to eliminate execution blind spots and keep teams aligned in real time. The platform helps manufacturers in aerospace, defense, industrial equipment, luxury, and transportation systems anticipate disruptions and coordinate decisions across production, planning, and supply chain functions.
Pimlico3 shared keywordsPimlico provides a gas sponsorship engine for blockchain applications that enables developers to abstract away gas fees from users. The platform allows apps to sponsor transactions, accept stablecoin payments for gas, or enforce custom policy rules, letting users transact on 100+ chains without needing native tokens or understanding gas costs.
Companies competing with Revilico for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Revilico do?
- Revilico builds an operating system for pharmaceutical R&D that unifies computational drug discovery tools—including molecular dynamics, quantum chemistry, generative chemistry, and virtual cell simulations—with integrated wet-lab validation. The platform serves pharmaceutical researchers and biotech companies developing small molecule drugs, covering all phases from target identification through lead optimization and preclinical development.
- Who founded Revilico?
- Revilico was founded by Christopher Korban, Christian Chung.
- Who are Revilico's investors?
- Revilico's investors include Mighty Capital.